Summary
We investigated the feasibility and the anti-tumour activity of weekly cisplatin and the simultaneous application of local hyperthermia in patients with a pelvic recurrence of cervical cancer in previously irradiated area. Dose levels of cisplatin 60 mg m–2, 70 mg m–2 and 80 mg m–2 were studied. Treatment objective of hyperthermia was the achievement of a tumour temperature of ≥ 42° for 60 min, during cisplatin administration. The protocol advised six weekly cycles of combined treatment. Nineteen patients, median age 47 years (range 26–71), were treated. A total of 89 cycles of combined treatment were administered. Even at the highest dose level of cisplatin, 80 mg m–2 weekly, no dose-limiting toxicity was observed. Leucocytopenia at scheduled retreatment resulted in 1 or 2 weeks postponement in five cases. Neurotoxicity and renal toxicity were mild or absent. Maximum tumour temperatures achieved ranged 39.7–43.6°C, mean 41.6 ± 0.7°C. All 19 patients were evaluable for response. One patient achieved a complete response that lasted 20 months, and nine patients achieved a partial response for a median duration of 6 months (range 4–50+ months), for an overall response rate of 53%. One patient subsequently underwent salvage surgery and currently remains free of disease at 4 years. We found that this combined hyperthermia- dose-intensive cisplatin regimen was well-tolerated. The true impact of the combination of cisplatin and locoregional hyperthermia can only be answered in a randomized study. Nonetheless, based on existing data on the poor efficacy of cisplatin in pelvic recurrent cervical cancer, we believe that the combined modality approach of weekly hyperthermia plus dose-intensive cisplatin is an attractive regimen, particularly if subsequent salvage surgery is available.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Baba, H., Siddik, Z. H., Strebel, F. R., Jenkings, G. N. & Bull, J. M. C. (1989). Increased therapeutic gain of combined cisdiamminedichloroplatinum (II) and whole body hyperthermia by optimal heat scheduling in the rat. Cancer Res 49: 7041–7044.
Brader, K. R., Morris, M., Levenback, C., Levy, L., Lucas, K. R. & Gershenson, D. M. (1998). Chemotherapy for cervical carcinoma: factors determining response and implications for clinical trial design. J Clin Oncol 16: 1879–1884.
Dahl, O. (1995). Interaction of heat and drugs in vitro and in vivo. In Thermoradiotherapy and Thermochemotherapy 1: Seegenschmiedt MH, Fessenden P, Vernon C Springer: Berlin 103–121.
Green, D. M., Burton, G. V., Cox, E. B., Hanson, D., Moore, J. & Oleson, J. R. (1989). A phase I/II study of combined cisplatin and hyperthermia treatment for refractory malignancy. Int J Hyperthermia 5: 13–21.
Hopewell, J. W. (1983). Radiation effects on vascular tissue. In Cytotoxic Insult to Tissue: Effect on Cell Lineages, Potten CS, Hendry JH Churchill Livingstone: Edinburgh 228–257.
Lele, S. B. & Piver, M. S. (1989). Weekly cisplatin induction chemotherapy in the treatment of recurrent cervical carcinoma. Gynecol Oncol 33: 6–8.
Osmak, M. & Perovic, S. (1989). Multiple fractions of gamma rays induced resistance to cis-dichloro-diammineplatinum (II) and methotrexate in human HeLa cells. Int J Radiat Oncol Biol Phys 16: 1537–1541.
Planting, A. S. T., van der Burg, M. E. L., de Boer-Dennert, M., Stoter, G. & Verweij, J. (1993). Phase I/II study of a short course of weekly cisplatin in patients with advanced solid tumours. Br J Cancer 68: 798–792.
Planting, A. S. T., de Mulder, P. H. M., de Graeff, A. & Verweij, J. (1997). Phase II study of weekly high-dose cisplatin for six cycles in patients with locally advanced squamous cell carcinoma of the head and neck. Eur J Cancer 33: 61–65.
Potter, M. E., Hatch, K. D., Potter, M. Y., Shingleton, H. M. & Baker, V. V. (1989). Factors effecting the response of recurrent squamous cell carcinoma of the cervix to cisplatin. Cancer 63: 1283–1286.
Rietbroek, R. C., Bakker, P. J. M., Schilthuis, M. S., Postma, A. J., Zum Vörde Sive Vörding, P. J., González González, D., Kurth, K. H., Bakker, A. J. & Veenhof, C. H. N. (1996). Feasibility, toxicity and preliminary results of weekly locoregional hyperthermia and cisplatin in patients with previously irradiated recurrent cervical carcinoma or locally advanced bladder cancer. Int J Radiat Oncol Biol Phys 34: 887–893.
Rietbroek, R. C., Schilthuis, M. S., Bakker, P. J. M., Dijk van, J. D. P., Postma, A. J., González González, D., Bakker, A. J., van der Velden, J., Helmerhorst, T. H. M. & Veenhof, C. H. N. (1998). Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with a previously irradiated recurrent carcinoma of the uterine cervix. Cancer 79: 935–943.
Turner, P. F. & Schaefermeyer, T. (1989). BSD-2000 approach for deep local and regional hyperthermia: clinical utility. Strahlenther Onkol 165: 700–704.
van der Zee, J., Peer-Valstar, J. N., Rietveld, P. J. M., de Graaf-Strukowska, L. & van Rhoon, G. C. (1998). Practical limitations of interstitial thermometry during deep hyperthermia. Int J Radiat Oncol Biol Phys 40: 1205–1212.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Wit, R., Zee, J., Burg, M. et al. A phase I/II study of combined weekly systemic cisplatin and locoregional hyperthermia in patients with previously irradiated recurrent carcinoma of the uterine cervix. Br J Cancer 80, 1387–1391 (1999). https://doi.org/10.1038/sj.bjc.6690533
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690533
Keywords
This article is cited by
-
Stereotactic Ablative Radiotherapy for Recurrent or Metastatic Gynecological Cancer: Extending Lives?
Current Treatment Options in Oncology (2020)
-
Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all
Radiation Oncology (2015)
-
Concurrent chemoradiotherapy with gemcitabine plus regional hyperthermia for locally advanced pancreatic carcinoma: initial experience
Radiation Medicine (2008)